[1] Cima RR, Pemberton JH. Medical and surgical management of chronic ulcerative colitis[J]. Arch Surg, 2005, 140:300-310. doi: 10.1001/archsurg.140.3.300 |
[2]
|
李论.重组人生长激素的临床应用和研究进展[J].国际儿科学杂志, 2017, 8:547-550. http://d.wanfangdata.com.cn/periodical/gwyx-ekx201708009 |
[3]
|
Deboer MD. Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerations[J]. Int J Pept, 2011, 2011:189-242. http://www.ncbi.nlm.nih.gov/pubmed/21845198 |
[4]
|
Theiss AL, Fruchtman S, Lund PK. Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I[J]. Inflamm Bowel Dis, 2004, 10:871-880. doi: 10.1097/00054725-200411000-00021 |
[5]
|
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Colitis Foundation of America, Bousvaros A, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America[J]. J Pediatr Gastroenterol Nutr, 2007, 44:653-674. doi: 10.1097/MPG.0b013e31805563f3 |
[6]
|
Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology[J]. Can J Gastroenterol, 2005, 19 Suppl A:5A-36A. http://cn.bing.com/academic/profile?id=dfc7fc932b17baaa78be42b5225707af&encoded=0&v=paper_preview&mkt=zh-cn |
[7]
|
Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications[J]. Gut, 2006, 55:749-753. doi: 10.1136/gut.2005.082909 |
[8]
|
中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2012年·广州)[J].胃肠病学, 2012, 12:763-781. http://d.wanfangdata.com.cn/Periodical/wcbx201212002 |
[9]
|
Guindi M, Riddell RH. Indeterminate colitis[J]. J Clin Pathol, 2004, 57:1233-1244. doi: 10.1136/jcp.2003.015214 |
[10]
|
Terashima S, Hoshino Y, Kanzaki N, et al. Ulcerative duodenitis accompanying ulcerative colitis[J]. J Clin Gastroenterol, 2001, 32:172-175. doi: 10.1097/00004836-200102000-00018 |
[11]
|
Sylvester FA. Inflammatory Bowel Disease: Effects on Bone and Mechanisms[J]. Adv Exp Med Biol, 2017, 1033:133-150. https://www.researchgate.net/publication/320834468_Inflammatory_Bowel_Disease_Effects_on_Bone_and_Mechanisms |
[12]
|
Mendes FD, Levy C, Enders FB, et al. Abnormal hepatic biochemistries in patients with inflammatory bowel disease[J]. Am J Gastroenterol, 2007, 102:344-350. doi: 10.1111/j.1572-0241.2006.00947.x |